IMMUCELL CORP /DE/ — Director's Dealing 2025

Jun 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2025-06-11

Reporting Person: Basse Gloria F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-11	Common stock $0.10 per value per share	M	3530	$4.81	Acquired	3530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-11	Non Qualified Stock Options (Right to buy)	$4.81	M	11470	Disposed	2025-06-29	Common Stock (11470)	Direct
2025-06-11	Non Qualified Stock Options (Right to buy)	$4.81	M	3.530	Disposed	2025-06-29	Common Stock (3530)	Direct

Footnotes

F1: (1) Shares acquired in stock option net exercise transaction with the Issuer.

F2: (2) Original stock option was for 15,000 shares. These shares resulted from a net exercise transaction, with 11,470 shares withheld (credited at $6.29 per share, the closing price of the Common stock on the date of exercise) in payment of the exercise price for 3,530 shares.